Exploring the causal pathway from ischemic stroke to atrial fibrillation: a network Mendelian randomization study
Open Access
- 15 January 2020
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 26 (1) , 1-9
Abstract
Background and purpose: Previous studies have found ischemic stroke is associated with atrial fibrillation. However, the causal association between ischemic stroke and atrial fibrillation is not clear. Furthermore, the network relationship among ischemic stroke, atrial fibrillation and its risk factors need further attention. This study aims to examine the potential causal association between ischemic stroke and atrial fibrillation and further to explore potential mediators in the causal pathway from ischemic stroke to atrial fibrillation. Methods: Summary statistics from the ISGC (case = 10,307 and control = 19,326) were used as ischemic stroke genetic instruments, AFGen Consortium data (case = 65,446 and control = 522,744) were used for atrial fibrillation, and other consortia data were used for potential mediators (fasting insulin, white blood cell count, procalcitonin, systolic and diastolic blood pressure, body mass index, waist circumference, and height). Under the framework of network Mendelian randomization, two-sample Mendelian randomization study was performed using summary statistics from several genome-wide association studies. Inverse-variance weighted method was performed to estimate causal effect. Results: Blood pressure mediates the causal pathways from ischemic stroke to atrial fibrillation. The total odds ratio of ischemic stroke on atrial fibrillation was 1.05 (95% confidence interval [CI], 1.02 to 1.07; P = 1.3 × 10−5). One-unit increase of genetically determined ischemic stroke was associated with 0.02 (DBP: 95% CI, 0.001 to 0.034, P = 0.029; SBP: 95% CI, 0.006 to 0.034, P = 0.003) upper systolic and diastolic blood pressure levels. Higher genetically determined systolic and diastolic blood pressure levels were associated with higher atrial fibrillation risk (DBP: RR, 1.18; 95% CI, 1.03 to 1.35; P = 0.012. SBP: RR, 1.18; 95% CI, 1.01 to 1.38; P = 0.04). Specially, we also found the bidirectional causality between blood pressure and ischemic stroke. Conclusions: Our study provided a strong evidence that raised blood pressure in stroke patients increases the risk of atrial fibrillation and active acute blood pressure lowering can improve the outcome in ischemic stroke patients.Keywords
Funding Information
- National Natural Science Foundation of China (81773547)
This publication has 60 references indexed in Scilit:
- Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor BlockersInternational Journal of Hypertension, 2013
- Avoiding bias from weak instruments in Mendelian randomization studiesInternational Journal of Epidemiology, 2011
- Sympathetic Nervous System and Blood Pressure in HumansHypertension, 2010
- Mendelian randomization as an instrumental variable approach to causal inferenceStatistical Methods in Medical Research, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- The relationship between higher blood pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians: meta-analysisEuropean Journal of Preventive Cardiology, 2006
- Blood Pressure Decrease During the Acute Phase of Ischemic Stroke Is Associated With Brain Injury and Poor Stroke OutcomeStroke, 2004
- Instrumental Variables Regression with Weak InstrumentsEconometrica, 1997
- Short-term Predictors of Incident Stroke in Older AdultsStroke, 1996
- The prognostic value of admission blood pressure in patients with acute stroke.Stroke, 1993